BMED vs TRUT

BMEDBiShares Health Innovation Active ETF

TRUTAVanEck Technology TruSector ETF

In short

BMED Most health ETFs are a shelf of mega-cap pharma. BMED's stock pickers hunt the other end: roughly 60 innovative and emerging health names tilted to mid and small caps worldwide, 0.55% net of a waiver through June 30, 2027.

TRUT Diversification rules force most tech ETFs to trim their biggest names. TRUT's answer: own the giants directly up to the legal line, then top up with sector ETFs so the portfolio mirrors the sector's real shape.

Stated mandate

BMED The Fund seeks to maximize total return through active investment in innovative and emerging healthcare companies.

TRUT The Fund seeks long-term capital appreciation through active investment in securities of information technology-related companies or instruments providing exposure to them.

Why people hold it

• BMED Mandate is specific: at least 80% of net assets in health sciences stocks, with the focus on mid- and small-cap innovators anywhere in the world, emerging markets included.sec.gov
• 0.55% net of a waiver through June 30, 2027 (0.77% gross), below the median fee among the 35 active sector funds in its group.
• Reach goes past drugmakers: devices, diagnostics, REITs that own hospitals, even animal and plant health sit inside the prospectus definition.sec.gov
• About 60 names means each pick carries weight, and the portfolio matches the innovation mandate it advertises, one of the stronger builds in its active sector peer group.

• TRUT The mechanism is the point. Fund rules cap one stock at 25% and stocks above 5% at 50% combined; TRUT fills the gap with targeted sector ETFs instead of overweighting smaller names.vaneck.comvaneck.com 2
• 0.14% a year for an actively managed fund, against a median near 0.65% across active US equity peers. Cheap enough to sit alongside index products.
• One of the two originals in VanEck's TruSector line, launched in 2025. The approach has since been extended across all 11 GICS sectors.vaneck.comvaneck.com 2
• About 80 positions, quarterly distributions, and steady day-to-day trading. On cost and tradability it lands in the upper tier of its active US equity cohort.

Worth knowing

• BMED Small fund, light trading. Spreads can widen and the market price can drift from net asset value, which bites hardest on bigger orders.sec.gov
• Mid caps, small caps and emerging-market names in a book of about 60 stocks move harder in both directions than mega-cap pharma.sec.gov
• That 0.55% leans on a waiver running to June 30, 2027; gross is 0.77%. Active healthcare peer TMED charges 0.44% with no waiver attached.

• TRUT Part of the exposure arrives through other ETFs rather than shares the fund holds outright. That is the workaround that makes uncapped weights possible, and it adds a layer.vaneck.com
• Uncapped means concentrated. Leaning fully into tech's largest companies ties results to a handful of mega-caps more tightly than a capped sector fund would.vaneck.com
• Launched August 2025, so there is only a short record of how closely the hybrid build actually shadows an uncapped tech benchmark.

Full BMED profile⁠

Full TRUT profile⁠